David Freyer, D.O.

David Freyer, D.O.

AFFILIATION AND TITLE

  • Director, Survivorship and Supportive Care Program Children’s Center for Cancer and Blood Diseases Children’s Hospital Los Angeles
  • Professor of Clinical Pediatrics and Medicine , Keck School of Medicine, University of Southern California

Dr. David Freyer is Director of the Survivorship and Supportive Care Program in the Children’s Center for Cancer and Blood Diseases at Children’s Hospital Los Angeles (CHLA), and is Professor of Clinical Pediatrics and Medicine at the Keck School of Medicine, University of Southern California (USC). In these positions, Dr. Freyer oversees clinical cancer survivorship and supportive care services and research, including hematology/oncology-related behavioral health, neuropsychology and health education. Dr. Freyer directs the LIFE Cancer Survivorship & Transition Service at CHLA, as well as the LIFE Clinic for Adult Cancer Survivors at the USC Norris Comprehensive Cancer Center. In December 2015, Dr. Freyer was appointed Co-Director of the Adolescent and Young Adult Cancers Program at the USC Norris, and now participates in the oversight of all aspects of AYA-focused services and research in this integrated program across CHLA and the USC Norris.

Dr. Freyer received his medical degree from the Des Moines University College of Osteopathic Medicine and Surgery. He took his pediatrics residency at Rush University Medical Center, and pediatric hematology/oncology fellowship at the University of Michigan Medical Center/CS Mott Children’s Hospital. In 2007, Dr. Freyer earned his MS in Clinical Research Design and Statistical Analysis at the University of Michigan School of Public Health.

Dr. Freyer’s clinical and research activities are focused primarily on cancer control and survivorship, including the recognition, characterization, management and prevention of short- and long-term morbidity of treatment, as well as AYA oncology, health care transition, and patient-reported outcomes. He is principal or co-investigator on several funded research grants. In the Children’s Oncology Group (COG), he serves as Chair of the COG AYA Oncology Discipline Committee and on the Cancer Control & Supportive Care and Survivorship & Outcomes Steering Committees. For numerous consecutive years, his clinical expertise has been recognized with citations in “Best Doctors in America.”